EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

An Improved Bayesian Pick‐the‐Winner (IBPW) Design for Randomized Phase II Clinical Trials

Wanni Lei, Maosen Peng, Nasser Altorki, Xi Kathy Zhou

Statistics in Medicine · 2026

DOI: 10.1002/sim.70348 ↗

At a glance

Journal article in Statistics in Medicine, 2026. Written by Wanni Lei and 3 co-authors. Institution: Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA. Major MEDLINE topics: Clinical Trials, Phase II as Topic, Randomized Controlled Trials as Topic, Research Design. 21 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCATS NIH HHS, NIH HHS, National Institutes of Health.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Phase II clinical trials play a pivotal role in drug development by screening a large number of drug candidates to identify those with promising preliminary efficacy for phase III testing. Trial designs that enable efficient decision‐making with small sample sizes and early futility stopping while controlling for type I and type II errors in hypothesis testing, such as Simon's two‐stage design, are preferred. Randomized multi‐arm trials are increasingly used in phase II settings to overcome the limitations associated with using historical controls as the reference. However, how to effectively balance efficiency and accurate decision‐making continues to be an important research topic. A notable development in phase II randomized design methodology is the Bayesian pick‐the‐winner (BPW) design proposed by Chen et al. [1]. Despite multiple appealing features, this method cannot easily control for overall type I and type II errors for winner selection. Here, we introduce an improved randomized two‐stage Bayesian pick‐the‐winner (IBPW) design that formalizes the winner‐selection based hypothesis testing, optimizes sample sizes and decision cut‐offs by strictly controlling the type I and type II errors under a set of flexible hypotheses for winner‐selection across two treatment arms. Simulation studies demonstrate that our new design offers improved operating characteristics for winner selection while retaining the desirable features of the BPW design.

Subjects

MeSH terms (MEDLINE)

Clinical Trials, Phase II as TopicRandomized Controlled Trials as TopicResearch DesignBayes TheoremHumansSample SizeComputer Simulation

Author keywords

Bayesian statisticsSimon's two‐stage designminimax designoptimal designphase II clinical trial designspick‐the‐winner design

Authors and institutions

  • Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA.
  • Department of Biostatistics and Data Science, University of Texas School of Public Health, Houston, Texas, USA.
  • Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Funding

  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Lei, W., Peng, M., Altorki, N., & Zhou, X. K. (2026). An Improved Bayesian Pick‐the‐Winner (IBPW) Design for Randomized Phase II Clinical Trials. Statistics in Medicine. https://doi.org/10.1002/sim.70348

Vancouver

Lei W, Peng M, Altorki N, Zhou XK. An Improved Bayesian Pick‐the‐Winner (IBPW) Design for Randomized Phase II Clinical Trials. Statistics in Medicine. 2026. doi:10.1002/sim.70348

BibTeX
@article{Lei2026,
  author = {Lei, Wanni and Peng, Maosen and Altorki, Nasser and Zhou, Xi Kathy},
  title = {An Improved Bayesian Pick‐the‐Winner (IBPW) Design for Randomized Phase II Clinical Trials},
  journal = {Statistics in Medicine},
  year = {2026},
  doi = {10.1002/sim.70348}
}
Start for free →